Nobel Prize in Medicine Awarded for Optogenetics Breakthrough

The 2026 Nobel Prize in Physiology or Medicine has been awarded to American Karl Deisseroth and Germans Peter Hegemann and Georg Nagel for discoveries concerning light-gated ion channels and optogenetics. The technique allows researchers to switch specific nerve cells on or off using light, establishing causal links between neural circuits and behavior.

Hegemann and Nagel identified channelrhodopsin, a light-sensitive protein in the single-celled alga Chlamydomonas, in the early 2000s. Deisseroth later adapted this protein into a controllable light switch for neurons, first demonstrating it in rat neurons in 2005 with millisecond precision.

“Optogenetics provides opportunities for mapping the brain in a way that we could once only dream of.”

Optogenetics has transformed neuroscience by replacing blurry correlation maps with precise functional mapping of memory, emotion, addiction, and movement circuits. Clinical applications include experimental vision restoration for retinal diseases like retinitis pigmentosa and Stargardt disease.

The laureates share a prize of 12 million Swedish kronor, approximately US$1.22 million. Nobel Committee Chair Per Svenningsson said optogenetics provides brain-mapping opportunities "we could once only dream of."